Search research articles
Contact Us
Filters
Showing results (1-10 of 69) with videos related to
Page
of 7
Sort By:
BMC Global and Public Health
|
December 16, 2024
Cost-effectiveness of interventions to improve case finding for tuberculosis: developing consensus to motivate investment
David W Dowdy, Hojoon Sohn
BMC Health Services Research
|
July 2, 2025
Who is protected and who is not? Evaluating the effects of the long-term care insurance system and disparities in healthcare utilization and costs of the South Korean elderly population
Minsung Sohn, Hojoon Sohn, Mankyu Choi
Biometrical Journal. Biometrische Zeitschrift
|
September 26, 2019
Meta-analysis of the difference of medians
Sean McGrath, Hojoon Sohn, Russell Steele, et al.
Expert Review of Anti-Infective Therapy
|
August 18, 2009
TB diagnostic tests: how do we figure out their costs?
Hojoon Sohn, Jessica Minion, Heidi Albert, et al.
Implementation Science : IS
|
September 30, 2020
Costing the implementation of public health interventions in resource-limited settings: a conceptual framework
Hojoon Sohn, Austin Tucker, Olivia Ferguson, et al.
Clinics in Chest Medicine
|
November 21, 2009
Novel and improved technologies for tuberculosis diagnosis: progress and challenges
Madhukar Pai, Jessica Minion, Hojoon Sohn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 5, 2018
Cost-effectiveness of Preventive Therapy for Tuberculosis With Isoniazid and Rifapentine Versus Isoniazid Alone in High-Burden Settings
Karl T Johnson, Gavin J Churchyard, Hojoon Sohn, et al.
PLOS Global Public Health
|
October 16, 2025
Impact of fluoroquinolone resistance on the cost-effectiveness of empiric treatment for multidrug- or rifampicin-resistant tuberculosis
Chaelin Kim, Sedona Sweeney, Hojoon Sohn, et al.
Plos One
|
December 26, 2024
Correction: Determining cost and placement decisions for moderate complexity NAATs for tuberculosis drug susceptibility testing
Akash Malhotra, Ryan Thompson, Margaretha De Vos, et al.
Plos One
|
August 24, 2023
Determining cost and placement decisions for moderate complexity NAATs for tuberculosis drug susceptibility testing
Akash Malhotra, Ryan Thompson, Margaretha De Vos, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 69) with videos related to
Sort By:
Page
of 7
BMC Global and Public Health
|
December 16, 2024
Cost-effectiveness of interventions to improve case finding for tuberculosis: developing consensus to motivate investment
David W Dowdy, Hojoon Sohn
BMC Health Services Research
|
July 2, 2025
Who is protected and who is not? Evaluating the effects of the long-term care insurance system and disparities in healthcare utilization and costs of the South Korean elderly population
Minsung Sohn, Hojoon Sohn, Mankyu Choi
Biometrical Journal. Biometrische Zeitschrift
|
September 26, 2019
Meta-analysis of the difference of medians
Sean McGrath, Hojoon Sohn, Russell Steele, et al.
Expert Review of Anti-Infective Therapy
|
August 18, 2009
TB diagnostic tests: how do we figure out their costs?
Hojoon Sohn, Jessica Minion, Heidi Albert, et al.
Implementation Science : IS
|
September 30, 2020
Costing the implementation of public health interventions in resource-limited settings: a conceptual framework
Hojoon Sohn, Austin Tucker, Olivia Ferguson, et al.
Clinics in Chest Medicine
|
November 21, 2009
Novel and improved technologies for tuberculosis diagnosis: progress and challenges
Madhukar Pai, Jessica Minion, Hojoon Sohn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 5, 2018
Cost-effectiveness of Preventive Therapy for Tuberculosis With Isoniazid and Rifapentine Versus Isoniazid Alone in High-Burden Settings
Karl T Johnson, Gavin J Churchyard, Hojoon Sohn, et al.
PLOS Global Public Health
|
October 16, 2025
Impact of fluoroquinolone resistance on the cost-effectiveness of empiric treatment for multidrug- or rifampicin-resistant tuberculosis
Chaelin Kim, Sedona Sweeney, Hojoon Sohn, et al.
Plos One
|
December 26, 2024
Correction: Determining cost and placement decisions for moderate complexity NAATs for tuberculosis drug susceptibility testing
Akash Malhotra, Ryan Thompson, Margaretha De Vos, et al.
Plos One
|
August 24, 2023
Determining cost and placement decisions for moderate complexity NAATs for tuberculosis drug susceptibility testing
Akash Malhotra, Ryan Thompson, Margaretha De Vos, et al.
Page
of 7